Nathan E. Pierce

Nathan Pierce practices at Los Angeles Center for Ear Nose Throat and Allergy in Montebello, California.

Nathan Pierce's NPI, 1538453634, was assigned on June 6, 2011. Nathan Pierce graduated from Rush Medical College in 2011. Nathan Pierce holds California license A143533.

Nathan Pierce's primary practice is Los Angeles Center for Ear Nose Throat and Allergy, at 433 N 4th St, Montebello, CA 90640 in Los Angeles County. The practice phone is (909) 569-9097.

Nathan Pierce's primary practice is Los Angeles Center for Ear Nose Throat and Allergy in Montebello, California. Nathan Pierce is also affiliated with Huntington Hospital. The medical group on file is Los Angeles Center for Ear, Nose, Throat and Allergy. Dmand AI also links Nathan Pierce to 3 more group practices and clinics, 3 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nathan Pierce practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Nathan Pierce's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Nathan Pierce is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Nathan Pierce's licenses on file in 3 states: California, Florida and Illinois.

Dmand AI lists hearing loss and impairment among the conditions Nathan Pierce treats.

CMS data shows 856 Medicare services from Nathan Pierce across 11 procedure codes in 2024, for 445 Medicare patients. Medicare paid $78,686 for them.

CMS counts 445 Medicare patients who saw Nathan Pierce in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 82% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nathan Pierce's median patient age at 51, with 55% women.

In 2024, Nathan Pierce wrote 738 Medicare Part D claims for 327 patients. 94% of them were for generic drugs. CMS names the drug for 664 of them, across 14 drugs with 11 or more claims each, at $14,665 in total drug cost. In 2023, CMS named 506 claims across 13 drugs.

Nathan Pierce accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nathan Pierce as offering telehealth.

Dmand AI links 1 paper to Nathan Pierce in 2014. Nathan Pierce's most frequent co-authors are Jeremiah Andrew Alt, MD, PhD and Patrick J. Antonelli, MD.

CMS Open Payments shows 139 general payments to Nathan Pierce from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Intersect ENT, Inc. paid the most, $2,128.

Nathan Pierce graduated from Rush Medical College in 2011.

Nathan Pierce is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.